Stemina Launches Autism Clinical Study
Stemina Biomarker Discovery Inc. today announced the launch of the largest clinical study of the metabolism of children with autism spectrum disorder (ASD) ever conducted. The Children’s Autism Metabolome Project or “CAMP” study will enroll 1,500 subjects from six sites across the country. CAMP will attempt to confirm that sets of metabolic biomarkers can detect subtypes of ASD.
- The NPDX AA test can identify ~30% of children with #autism spectrum disorder (ASD) with an increased risk of an AS… https://t.co/R1s2P7oIdB3 hours ago
- The holidays, which can be overstimulating even for neurotypical people, are coming soon. Adults with #autism think… https://t.co/PSA0EFahUn6 hours ago
- Save yourself a phone call – learn from the list of questions and answers about the NPDX AA test, written to addres… https://t.co/UcVH5ssk0118 hours ago